Brian C. Shonesy - Publications

Affiliations: 
Molecular Physiology and Biophysics Vanderbilt University, Nashville, TN 
Area:
Synaptic Physiology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Shonesy BC, Stephenson JR, Marks CR, Colbran RJ. Cyclic AMP-dependent protein kinase and D1 dopamine receptors regulate diacylglycerol lipase-α and synaptic 2-arachidonoyl glycerol signaling. Journal of Neurochemistry. e14972. PMID 31985073 DOI: 10.1111/jnc.14972  1
2018 Marks CR, Shonesy BC, Wang X, Stephenson JR, Niswender C, Colbran RJ. Activated CaMKIIα binds to the mGlu5 metabotropic glutamate receptor and modulates calcium mobilization. Molecular Pharmacology. PMID 30282777 DOI: 10.1124/mol.118.113142  1
2017 Shonesy BC, Parrish WP, Haddad HK, Stephenson JR, Báldi R, Bluett RJ, Marks CR, Centanni SW, Folkes OM, Spiess K, Augustin SM, Mackie K, Lovinger DM, Winder DG, Patel S, et al. Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior. Biological Psychiatry. PMID 29458998 DOI: 10.1016/j.biopsych.2017.11.036  1
2017 Bluett RJ, Báldi R, Haymer A, Gaulden AD, Hartley ND, Parrish WP, Baechle J, Marcus DJ, Mardam-Bey R, Shonesy BC, Uddin MJ, Marnett LJ, Mackie K, Colbran RJ, Winder DG, et al. Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nature Communications. 8: 14782. PMID 28348378 DOI: 10.1038/ncomms14782  1
2017 Stephenson JR, Wang X, Perfitt TL, Parrish WP, Shonesy BC, Marks CR, Mortlock DP, Nakagawa T, Sutcliffe JS, Colbran RJ. A novel human CAMK2A mutation disrupts dendritic morphology and synaptic transmission, and causes ASD-related behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28130356 DOI: 10.1523/JNEUROSCI.2068-16.2017  1
2015 Patel S, Shonesy BC, Bluett RJ, Winder DG, Colbran RJ. The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence from Two Recent Genetic Endocannabinoid Deficiency Models. Biological Psychiatry. PMID 26212898 DOI: 10.1016/j.biopsych.2015.04.028  1
2015 Baucum AJ, Shonesy BC, Rose KL, Colbran RJ. Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain. Acs Chemical Neuroscience. 6: 615-31. PMID 25650780 DOI: 10.1021/cn500337u  1
2015 Shonesy BC, Winder DG, Patel S, Colbran RJ. The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. Neuropharmacology. 91: 57-62. PMID 25484252 DOI: 10.1016/j.neuropharm.2014.11.026  1
2014 Shonesy BC, Bluett RJ, Ramikie TS, Báldi R, Hermanson DJ, Kingsley PJ, Marnett LJ, Winder DG, Colbran RJ, Patel S. Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Reports. 9: 1644-53. PMID 25466252 DOI: 10.1016/j.celrep.2014.11.001  1
2014 Shonesy BC, Jalan-Sakrikar N, Cavener VS, Colbran RJ. CaMKII: a molecular substrate for synaptic plasticity and memory. Progress in Molecular Biology and Translational Science. 122: 61-87. PMID 24484698 DOI: 10.1016/B978-0-12-420170-5.00003-9  1
2013 Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nature Neuroscience. 16: 1291-8. PMID 23912944 DOI: 10.1038/nn.3480  1
2013 Shonesy BC, Wang X, Rose KL, Ramikie TS, Cavener VS, Rentz T, Baucum AJ, Jalan-Sakrikar N, Mackie K, Winder DG, Patel S, Colbran RJ. CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Nature Neuroscience. 16: 456-63. PMID 23502535 DOI: 10.1038/nn.3353  1
2012 Parameshwaran K, Buabeid MA, Karuppagounder SS, Uthayathas S, Thiruchelvam K, Shonesy B, Dityatev A, Escobar MC, Dhanasekaran M, Suppiramaniam V. Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cellular and Molecular Life Sciences : Cmls. 69: 829-41. PMID 22033836 DOI: 10.1007/s00018-011-0805-4  1
2012 Shonesy BC, Thiruchelvam K, Parameshwaran K, Rahman EA, Karuppagounder SS, Huggins KW, Pinkert CA, Amin R, Dhanasekaran M, Suppiramaniam V. Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiology of Aging. 33: 430.e5-18. PMID 21256630 DOI: 10.1016/j.neurobiolaging.2010.12.002  1
2011 Gustin RM, Shonesy BC, Robinson SL, Rentz TJ, Baucum AJ, Jalan-Sakrikar N, Winder DG, Stanwood GD, Colbran RJ. Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice. Molecular and Cellular Neurosciences. 47: 286-92. PMID 21627991 DOI: 10.1016/j.mcn.2011.05.006  1
2008 Kanju PM, Parameshwaran K, Sims C, Bahr BA, Shonesy BC, Suppiramaniam V. Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation. Experimental Neurology. 214: 55-61. PMID 18687330 DOI: 10.1016/j.expneurol.2008.07.010  1
2008 Wijayawardhane N, Shonesy BC, Vaithianathan T, Pandiella N, Vaglenova J, Breese CR, Dityatev A, Suppiramaniam V. Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity. Neurobiology of Disease. 29: 81-91. PMID 17916430 DOI: 10.1016/j.nbd.2007.08.001  1
2007 Wijayawardhane N, Shonesy BC, Vaglenova J, Vaithianathan T, Carpenter M, Breese CR, Dityatev A, Suppiramaniam V. Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission. Neurobiology of Disease. 26: 696-706. PMID 17493826 DOI: 10.1016/j.nbd.2007.03.009  1
2007 Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse (New York, N.Y.). 61: 367-74. PMID 17372971 DOI: 10.1002/syn.20386  1
Show low-probability matches.